Maximus vs Telos Rx: Compare Pricing, Drugs, and Telemedicine

September 11, 2026

Quick verdict: For the simplest low flat monthly price on compounded semaglutide, Maximus is the clearer direct-pay option at $132.99 per month; for lower advertised starting prices and an option that lists both semaglutide and tirzepatide, Telos Rx advertises semaglutide as low as $99 and tirzepatide as low as $139, if a licensed provider approves you. This comparison focuses on pricing, drug options, clinician review and regulatory status, shipping and availability, and program scale to help decide between Maximus vs Telos Rx.

Explore Maximus pricing and program

Pricing and billing: clear flat rate versus advertised starting prices

Maximus advertises a low flat rate of $132.99 per month for compounded semaglutide and describes a straightforward direct-pay model with no insurance billing. Telos Rx presents lower starting figures on its landing page: semaglutide as low as $99 per month and tirzepatide as low as $139 per month, but repeatedly notes prices, eligibility and final terms depend on the live offer and clinician review. Neither provider bills insurance based on the captured evidence; Maximus emphasizes a predictable flat rate while Telos Rx emphasizes conditional “as low as” pricing.

CTA and next step

See Telos Rx current pricing and eligibility

Medication options and clinical matching

Maximus positions itself around compounded semaglutide delivered once weekly. Telos Rx lists both compounded semaglutide and compounded tirzepatide, describing tirzepatide as acting on GLP-1 and GIP and noting a US-licensed provider decides which molecule is right for you. That means Telos Rx documents two medication pathways on its landing page, while Maximus focuses on semaglutide.

Clinician review, telemedicine access, and approval language

Both providers require medical approval by licensed clinicians. Maximus highlights convenient telemedicine access and prescriptions approved by licensed doctors, with prescriptions filled through trusted U.S. pharmacies. Telos Rx states medications are prescribed only after review by a US-licensed provider and that treatment is available only when a licensed clinician determines it is medically appropriate. Telos Rx also explicitly states pay $0 if not approved in its captured content.

Criteria	Maximus	Telos Rx
Starting price	$132.99 per month	Semaglutide as low as $99; tirzepatide as low as $139
Medications offered	Compounded semaglutide	Compounded semaglutide and compounded tirzepatide
Clinician review	Prescriptions approved by licensed doctors via telemedicine	Prescribed only after review by a US-licensed provider
Pharmacy sourcing	Filled through trusted U.S. pharmacies	Compounded medications, pharmacy details not published on captured page
Shipping and refunds	Free priority shipping; medication costs refunded if not approved	Pay $0 if not approved noted on landing page
Regulatory note	Compounded medications are not FDA-approved	Compounded medications are not FDA-approved

Shipping, availability, and program scale

Maximus states free priority or expedited shipping and notes availability in all 50 states except Mississippi for its Weight Loss Protocol. Maximus also admits it has a smaller patient base and fewer public reviews than larger competitors. Telos Rx cautions that pricing, eligibility, pharmacy, state coverage and renewal terms may change and captures fewer public program details on the landing page evidence.

Start the Maximus telemedicine process

Regulatory and safety language to remember

Both providers’ captured content includes the regulatory note that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Telos Rx repeats that individual results vary and are not guaranteed. Maximus also repeats that its medication is compounded, not an FDA approved finished product, while noting it uses the same active ingredient as branded GLP-1 medications.

Check clinician requirements at Telos Rx

Final take: Maximus vs Telos Rx

In short, Maximus is a direct-pay, telemedicine-first option with a clear flat monthly price of $132.99 for compounded semaglutide, shipping and domestic pharmacy sourcing and availability in most states per captured content. Telos Rx advertises lower starting prices and an additional compound option in tirzepatide but frames pricing and access as conditional on clinician approval and live offer terms. Both clearly state compounded medications are not FDA-approved.

Choose Maximus if…

You want a straightforward direct-pay telemedicine program focused on compounded semaglutide with a published flat rate of $132.99 per month, prescriptions approved by licensed doctors, and medication filled through trusted U.S. pharmacies.

Choose Telos Rx if…

You want the option of lower advertised starting prices and access to both compounded semaglutide and compounded tirzepatide, understanding final price and eligibility are subject to clinician review and live offer terms.

Compare Maximus features again

Primary keyword: Maximus vs Telos Rx